1. Home
  2. BNZI vs VRAX Comparison

BNZI vs VRAX Comparison

Compare BNZI & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNZI
  • VRAX
  • Stock Information
  • Founded
  • BNZI 2016
  • VRAX 2013
  • Country
  • BNZI United States
  • VRAX United Kingdom
  • Employees
  • BNZI N/A
  • VRAX N/A
  • Industry
  • BNZI
  • VRAX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • BNZI
  • VRAX Health Care
  • Exchange
  • BNZI Nasdaq
  • VRAX Nasdaq
  • Market Cap
  • BNZI 8.9M
  • VRAX 7.3M
  • IPO Year
  • BNZI N/A
  • VRAX 2022
  • Fundamental
  • Price
  • BNZI $1.54
  • VRAX $1.63
  • Analyst Decision
  • BNZI Strong Buy
  • VRAX
  • Analyst Count
  • BNZI 1
  • VRAX 0
  • Target Price
  • BNZI $125.00
  • VRAX N/A
  • AVG Volume (30 Days)
  • BNZI 4.5M
  • VRAX 253.3K
  • Earning Date
  • BNZI 02-28-2025
  • VRAX 02-05-2025
  • Dividend Yield
  • BNZI N/A
  • VRAX N/A
  • EPS Growth
  • BNZI N/A
  • VRAX N/A
  • EPS
  • BNZI N/A
  • VRAX N/A
  • Revenue
  • BNZI $4,310,782.00
  • VRAX $84,872.00
  • Revenue This Year
  • BNZI $5.58
  • VRAX $5,169.18
  • Revenue Next Year
  • BNZI $58.87
  • VRAX $66.97
  • P/E Ratio
  • BNZI N/A
  • VRAX N/A
  • Revenue Growth
  • BNZI N/A
  • VRAX 7.03
  • 52 Week Low
  • BNZI $1.21
  • VRAX $0.60
  • 52 Week High
  • BNZI $76.00
  • VRAX $9.00
  • Technical
  • Relative Strength Index (RSI)
  • BNZI 47.76
  • VRAX 38.98
  • Support Level
  • BNZI $1.48
  • VRAX $1.58
  • Resistance Level
  • BNZI $1.81
  • VRAX $2.29
  • Average True Range (ATR)
  • BNZI 0.27
  • VRAX 0.22
  • MACD
  • BNZI -0.00
  • VRAX -0.04
  • Stochastic Oscillator
  • BNZI 21.23
  • VRAX 11.77

About BNZI Banzai International Inc.

Banzai International Inc is a marketing technology (MarTech) company that produces data-driven marketing and sales solutions for businesses of all sizes. Its mission is to help its customers accomplish their mission by enabling better marketing, sales and customer engagement outcomes. The company sells its products using a recurring subscription license model typical in SaaS businesses. Pricing tiers for its main product, Demio, are based on the number of host-capable users, desired feature sets, and maximum audience size.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.

Share on Social Networks: